The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors | MicrobiomeTrials← Back to trialsNCT05124951
The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-09-15Est. Completion: 2026-10-31
Enrollment target: 150 participants Locations- Beijing Tiantan Hospital, Beijing, China
Other microbiome trials you might be interested in
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphomaPrimary CNS Tumors
Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult…
Los Angeles, United StatesEst. completion Sep 30, 2026
Medulloblastoma, ChildhoodCerebral Primitive Neuroectodermal TumorEpendymoma
The Register is based on the study HIT 2000 that recruited patients until 31.12.2011. All german patients with intracran…
Hamburg, Germany
Completed Dec 2014
Retinoblastoma, Extraocular
Retinoblastoma is the most common intraocular malignancy in infancy and childhood. The overall survival rate of retinobl…
Shanghai, ChinaEst. completion May 1, 2028